Search research articles
Contact Us
Filters
Showing results (131-140 of 183) with videos related to
Page
of 19
Sort By:
Blood Advances
|
May 13, 2020
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL
Sarit Assouline, Shen Li, Christian Gisselbrecht, et al.
British Journal of Haematology
|
June 9, 2020
Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma
Lourdes Calvente, Rosemarie Tremblay-LeMay, Wei Xu, et al.
Leukemia & Lymphoma
|
October 11, 2018
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†
Tony Reiman, Kerry J Savage, Michael Crump, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials
Donald A Berry, Naoto T Ueno, Marcella M Johnson, et al.
Blood
|
July 5, 2005
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis
Bronno van der Holt, Bob Löwenberg, Alan K Burnett, et al.
The New England Journal of Medicine
|
December 14, 2011
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma
Ralph M Meyer, Mary K Gospodarowicz, Joseph M Connors, et al.
Blood
|
August 5, 2017
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
Michael Crump, Sattva S Neelapu, Umar Farooq, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2024
Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study
Tycel Jovelle Phillips, Carmelo Carlo-Stella, Franck Morschhauser, et al.
Hematological Oncology
|
March 3, 2026
Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T
Inna Y Gong, Meenakshi Jeeva, Katrina Hueniken, et al.
Leukemia & Lymphoma
|
May 16, 2017
Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study<sup></sup>
Tanya Skamene, Michael Crump, Kerry J Savage, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 183) with videos related to
Sort By:
Page
of 19
Blood Advances
|
May 13, 2020
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL
Sarit Assouline, Shen Li, Christian Gisselbrecht, et al.
British Journal of Haematology
|
June 9, 2020
Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma
Lourdes Calvente, Rosemarie Tremblay-LeMay, Wei Xu, et al.
Leukemia & Lymphoma
|
October 11, 2018
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†
Tony Reiman, Kerry J Savage, Michael Crump, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials
Donald A Berry, Naoto T Ueno, Marcella M Johnson, et al.
Blood
|
July 5, 2005
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis
Bronno van der Holt, Bob Löwenberg, Alan K Burnett, et al.
The New England Journal of Medicine
|
December 14, 2011
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma
Ralph M Meyer, Mary K Gospodarowicz, Joseph M Connors, et al.
Blood
|
August 5, 2017
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
Michael Crump, Sattva S Neelapu, Umar Farooq, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2024
Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study
Tycel Jovelle Phillips, Carmelo Carlo-Stella, Franck Morschhauser, et al.
Hematological Oncology
|
March 3, 2026
Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T
Inna Y Gong, Meenakshi Jeeva, Katrina Hueniken, et al.
Leukemia & Lymphoma
|
May 16, 2017
Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study<sup></sup>
Tanya Skamene, Michael Crump, Kerry J Savage, et al.
Page
of 19